Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 378 participants.

Also called NCT07021313

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 378 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07021313
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07021313. Randomized; double masking; primary purpose treatment. Start 2025-06-30 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation
Acronym
DOPPIO
Intervention (Device)
Pulmonary vein isolation by percutaneous endocardial catheter ablation using the FARAPULSE pulsed high voltage electrical field system in patients with atrial fibrillation
Intervention (Device)
Pulmonary vein isolation by percutaneous endocardial catheter ablation using a pentaspline pulsed high voltage electrical field system in patients with atrial fibrillation
Lead sponsor
R&D Cardiologie (class: other)

Record details

Record id
cardio:ct-nct07021313
Content hash
7ddac550573d7db60e5922556f6592315644389cd39ed544cb636b6d97a83049